Top Markets
#1 Derive Derive +36.07%
#2 Cross Cross +18.56%
#3 The Bitcoin Bull The Bitcoin Bull +14.92%
#4 Geodnet Geodnet +10.04%
#5 Gama Token Gama Token +9.18%
#6 Biconomy Biconomy +8.72%
#7 Starpower Starpower +7.90%
#8 Humanity Humanity +7.57%
#9 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +6.71%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +6.64%
Coin of the day
Derive Derive
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Telo Genomics Corp. Telo Genomics Corp.

Telo Genomics Corp.

TELO
Rang in Aktien #35884
Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on... Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on creating and bringing to market advanced predictive solutions. Its core mission is to enable personalized treatment approaches for individuals suffering from specific health conditions. The company's primary innovation is a sophisticated telomere analysis platform, which serves both to diagnose diseases and to forecast patient outcomes. This technology, often integrated with liquid biopsies, provides crucial insights for applications in both cancer and neurological illnesses. Their leading product, Telo-MM, is specifically designed to arm medical professionals with vital, actionable information for effectively managing Multiple Myeloma, a serious blood cancer. Additionally, Telo Genomics offers TeloView, a proprietary software system capable of precisely measuring individual patient telomere characteristics. Telo Genomics caters to a broad spectrum of clients, including diagnostic pathologists, clinical doctors, academic researchers, and pharmaceutical developers. A notable endorsement of its technology is a collaborative agreement with the renowned Mayo Clinic, aimed at validating the Telo-MM diagnostic tests for multiple myeloma. Founded in 2014 and based in Toronto, Canada, the company adopted its current name, Telo Genomics Corp., in April 2019, having previously operated as 3D Signatures Inc.
Aktienkurs
$0.03302716
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$3.32M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-34.80%
Land
CA
Handel Telo Genomics Corp. (TELO)

Kategorie

Healthcare
Anzahl der ausstehenden Aktien von Telo Genomics Corp. (TELO)
Anzahl der ausstehenden Aktien zum August 2026: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Telo Genomics Corp. beträgt die aktuelle Anzahl der ausstehenden Aktien 0. Am Ende von August 2026 hatte das Unternehmen 0 ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Telo Genomics Corp. (TELO) von 2026 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
Nicht genügend Daten für die angegebenen Daten.
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 371.00M -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 705.30M -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 143.28M -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 80.10M -
US